Articles with "bench clinic" as a keyword



Photo from archive.org

Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5.

Sign Up to like & get
recommendations!
Published in 2017 at "Cytokine"

DOI: 10.1016/j.cyto.2016.11.011

Abstract: T helper 2 cells produce a number of cytokines including inteleukin (IL)-5, IL-4 and IL-13. Group 2 innate lymphoid cells (ILC2s) also produce IL-5 under sterile conditions. IL-5 is interdigitating homodimeric glycoprotein and a member… read more here.

Keywords: diseases bench; contribution discovery; allergic diseases; discovery interleukin ... See more keywords
Photo from wikipedia

Coenzyme Q10: From bench to clinic in aging diseases, a translational review

Sign Up to like & get
recommendations!
Published in 2018 at "Critical Reviews in Food Science and Nutrition"

DOI: 10.1080/10408398.2018.1442316

Abstract: ABSTRACT Coenzyme Q10 (CoQ10) is a ubiquitous molecule present in all eukaryotic organisms whose principal role in the cell is related to its participation in the electron transport chain in the inner mitochondrial membrane. CoQ10… read more here.

Keywords: q10 bench; coenzyme; coenzyme q10; bench clinic ... See more keywords
Photo from wikipedia

Diabetic Cognitive Dysfunction: From Bench to Clinic.

Sign Up to like & get
recommendations!
Published in 2019 at "Current medicinal chemistry"

DOI: 10.2174/1871530319666190206225635

Abstract: Type 2 diabetes increases the risk of developing cognitive dysfunction in the elderly in the form of short-term memory and executive function impairment. Genetic and diet-induced models of type 2 diabetes further support this link,… read more here.

Keywords: diabetic cognitive; dysfunction; cognitive dysfunction; type diabetes ... See more keywords
Photo by nci from unsplash

Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2021.698425

Abstract: Programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1) inhibitors target the important molecular interplay between PD-1 and PD-L1, a key pathway contributing to immune evasion in the tumor microenvironment (TME). Long-term clinical benefit has… read more here.

Keywords: imaging pathway; pet; bench clinic; expression ... See more keywords